<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T10:35:17Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:7308367" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:7308367</identifier>
        <datestamp>2020-06-26</datestamp>
        <setSpec>tp</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Transl Psychiatry</journal-id>
              <journal-id journal-id-type="iso-abbrev">Transl Psychiatry</journal-id>
              <journal-title-group>
                <journal-title>Translational Psychiatry</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2158-3188</issn>
              <publisher>
                <publisher-name>Nature Publishing Group UK</publisher-name>
                <publisher-loc>London</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC7308367</article-id>
              <article-id pub-id-type="pmcid">PMC7308367</article-id>
              <article-id pub-id-type="pmc-uid">7308367</article-id>
              <article-id pub-id-type="pmid">32572020</article-id>
              <article-id pub-id-type="publisher-id">885</article-id>
              <article-id pub-id-type="doi">10.1038/s41398-020-00885-4</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Acute oxytocin effects in inferring others’ beliefs and social emotions in people at clinical high risk for psychosis</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" corresp="yes">
                  <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6055-8397</contrib-id>
                  <name>
                    <surname>Schmidt</surname>
                    <given-names>André</given-names>
                  </name>
                  <address>
                    <email>andre.schmidt@unibas.ch</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3011-8643</contrib-id>
                  <name>
                    <surname>Davies</surname>
                    <given-names>Cathy</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4029-3720</contrib-id>
                  <name>
                    <surname>Paloyelis</surname>
                    <given-names>Yannis</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Meyer</surname>
                    <given-names>Nicholas</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>De Micheli</surname>
                    <given-names>Andrea</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                  <xref ref-type="aff" rid="Aff5">5</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ramella-Cravaro</surname>
                    <given-names>Valentina</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Provenzani</surname>
                    <given-names>Umberto</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                  <xref ref-type="aff" rid="Aff6">6</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Aoki</surname>
                    <given-names>Yuta</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff7">7</xref>
                  <xref ref-type="aff" rid="Aff8">8</xref>
                  <xref ref-type="aff" rid="Aff9">9</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Rutigliano</surname>
                    <given-names>Grazia</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Cappucciati</surname>
                    <given-names>Marco</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8920-3407</contrib-id>
                  <name>
                    <surname>Oliver</surname>
                    <given-names>Dominic</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Murguia</surname>
                    <given-names>Silvia</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff10">10</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Zelaya</surname>
                    <given-names>Fernando</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Allen</surname>
                    <given-names>Paul</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                  <xref ref-type="aff" rid="Aff11">11</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Shergill</surname>
                    <given-names>Sukhi</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Morrison</surname>
                    <given-names>Paul</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4299-1941</contrib-id>
                  <name>
                    <surname>Williams</surname>
                    <given-names>Steve</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Taylor</surname>
                    <given-names>David</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff12">12</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5792-3987</contrib-id>
                  <name>
                    <surname>Borgwardt</surname>
                    <given-names>Stefan</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff13">13</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Yamasue</surname>
                    <given-names>Hidenori</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff7">7</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>McGuire</surname>
                    <given-names>Philip</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                  <xref ref-type="aff" rid="Aff5">5</xref>
                  <xref ref-type="aff" rid="Aff14">14</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3582-6788</contrib-id>
                  <name>
                    <surname>Fusar-Poli</surname>
                    <given-names>Paolo</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                  <xref ref-type="aff" rid="Aff6">6</xref>
                  <xref ref-type="aff" rid="Aff14">14</xref>
                </contrib>
                <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.6612.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 0642</institution-id><institution>Department of Psychiatry (UPK), </institution><institution>University of Basel, </institution></institution-wrap>Basel, Switzerland </aff>
                <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.13097.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 2322 6764</institution-id><institution>Early Psychosis: Interventions and Clinical-detection (EPIC) lab, Department of Psychosis Studies, </institution><institution>Institute of Psychiatry, Psychology &amp; Neuroscience, King’s College London, </institution></institution-wrap>London, UK </aff>
                <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.13097.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 2322 6764</institution-id><institution>Department of Neuroimaging, </institution><institution>Institute of Psychiatry, Psychology &amp; Neuroscience, King’s College London, </institution></institution-wrap>London, UK </aff>
                <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.13097.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 2322 6764</institution-id><institution>Department of Psychosis Studies, </institution><institution>Institute of Psychiatry, Psychology &amp; Neuroscience, King’s College London, </institution></institution-wrap>London, UK </aff>
                <aff id="Aff5"><label>5</label>National Institute for Health Research (NIHR) Biomedical Research Centre (BRC), South London and Maudsley NHS Foundation Trust, London, UK </aff>
                <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.8982.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 1762 5736</institution-id><institution>Department of Brain and Behavioural Sciences, </institution><institution>University of Pavia, </institution></institution-wrap>Pavia, Italy </aff>
                <aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.505613.4</institution-id><institution>Department of Psychiatry, </institution><institution>Hamamatsu University School of Medicine, </institution></institution-wrap>Shizuoka, Japan </aff>
                <aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="GRID">grid.410714.7</institution-id><institution-id institution-id-type="ISNI">0000 0000 8864 3422</institution-id><institution>Medical Institute of Developmental Disabilities Research, </institution><institution>Showa University, </institution></institution-wrap>Tokyo, Japan </aff>
                <aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="GRID">grid.63906.3a</institution-id><institution-id institution-id-type="ISNI">0000 0004 0377 2305</institution-id><institution>Department of Psychosocial Medicine, </institution><institution>National Center for Child Health and Development, </institution></institution-wrap>Tokyo, Japan </aff>
                <aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="GRID">grid.450709.f</institution-id><institution-id institution-id-type="ISNI">0000 0004 0426 7183</institution-id><institution>Tower Hamlets Early Detection Service (THEDS), East London NHS Foundation Trust, </institution></institution-wrap>London, UK </aff>
                <aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="GRID">grid.35349.38</institution-id><institution-id institution-id-type="ISNI">0000 0001 0468 7274</institution-id><institution>Department of Psychology, </institution><institution>University of Roehampton, </institution></institution-wrap>London, UK </aff>
                <aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="GRID">grid.13097.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 2322 6764</institution-id><institution>Institute of Pharmaceutical Science, King’s College London, </institution></institution-wrap>London, UK </aff>
                <aff id="Aff13"><label>13</label><institution-wrap><institution-id institution-id-type="GRID">grid.4562.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 0057 2672</institution-id><institution>Department of Psychiatry and Psychotherapy, </institution><institution>University of Lübeck, </institution></institution-wrap>Lübeck, Germany </aff>
                <aff id="Aff14"><label>14</label><institution-wrap><institution-id institution-id-type="GRID">grid.37640.36</institution-id><institution-id institution-id-type="ISNI">0000 0000 9439 0839</institution-id><institution>Outreach and Support in South London (OASIS) Service, South London and Maudsley NHS Foundation Trust, </institution></institution-wrap>London, UK </aff>
              </contrib-group>
              <pub-date pub-type="epub">
                <day>22</day>
                <month>6</month>
                <year>2020</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>22</day>
                <month>6</month>
                <year>2020</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2020</year>
              </pub-date>
              <volume>10</volume>
              <elocation-id>203</elocation-id>
              <history>
                <date date-type="received">
                  <day>23</day>
                  <month>1</month>
                  <year>2020</year>
                </date>
                <date date-type="rev-recd">
                  <day>19</day>
                  <month>5</month>
                  <year>2020</year>
                </date>
                <date date-type="accepted">
                  <day>26</day>
                  <month>5</month>
                  <year>2020</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© The Author(s) 2020</copyright-statement>
                <license license-type="OpenAccess">
                  <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
                </license>
              </permissions>
              <abstract id="Abs1">
                <p id="Par1">Social deficits are key hallmarks of the Clinical High Risk for Psychosis (CHR-P) state and of established psychotic disorders, and contribute to impaired social functioning, indicating a potential target for interventions. However, current treatments do not significantly ameliorate social impairments in CHR-P individuals. Given its critical role in social behaviour and cognition, the oxytocinergic (OT) system is a promising target for novel interventions in CHR-P subjects. In a double-blind, placebo-controlled, crossover design, 30 CHR-P males were studied using functional magnetic resonance imaging (fMRI) on two occasions, once after 40IU self-administered intranasal OT and once after placebo. A modified version of the Sally-Anne task was used to assess brain activation during inferring others’ beliefs and social emotions. The Reading the Mind in the Eyes Test was acquired prior to the first scan to test whether OT effects were moderated by baseline social-emotional abilities. OT did not modulate behavioural performances but reduced activation in the bilateral inferior frontal gyrus compared with placebo while inferring others’ social emotions. Furthermore, the relationship between brain activation and task performance after OT administration was moderated by baseline social-emotional abilities. While task accuracy during inferring others’ social emotion increased with decreasing activation in the left inferior frontal gyrus in CHR-P individuals with low social-emotional abilities, there was no such relationship in CHR-P individuals with high social-emotional abilities. Our findings may suggest that acute OT administration enhances neural efficiency in the inferior frontal gyrus during inferring others’ social emotions in those CHR-P subjects with low baseline social-emotional abilities.</p>
              </abstract>
              <kwd-group kwd-group-type="npg-subject">
                <title>Subject terms</title>
                <kwd>Schizophrenia</kwd>
                <kwd>Physiology</kwd>
              </kwd-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100000265</institution-id>
                      <institution>RCUK | Medical Research Council (MRC)</institution>
                    </institution-wrap>
                  </funding-source>
                </award-group>
              </funding-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100000272</institution-id>
                      <institution>DH | National Institute for Health Research (NIHR)</institution>
                    </institution-wrap>
                  </funding-source>
                </award-group>
              </funding-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="FundRef">https://doi.org/10.13039/100009362</institution-id>
                      <institution>South London and Maudsley NHS Foundation Trust</institution>
                    </institution-wrap>
                  </funding-source>
                </award-group>
              </funding-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000874</institution-id>
                      <institution>Brain and Behavior Research Foundation (Brain &amp; Behavior Research Foundation)</institution>
                    </institution-wrap>
                  </funding-source>
                </award-group>
              </funding-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>issue-copyright-statement</meta-name>
                  <meta-value>© The Author(s) 2020</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <sec id="Sec1" sec-type="introduction">
              <title>Introduction</title>
              <p id="Par2">Deficits in social functioning are core features of psychosis and predictive for the onset, development, course and outcome of this illness<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. Social functioning impairments are a distinctive characteristic of individuals at Clinical High Risk for Psychosis (CHR-P) to the point that they represent the most impaired neurocognitive domain (Hedge’s <italic>g</italic> = 0.55) in this patient population<sup><xref ref-type="bibr" rid="CR2">2</xref>–<xref ref-type="bibr" rid="CR4">4</xref></sup>. However, currently available approaches for CHR-P individuals fail to ameliorate their social impairments, indicating the need for novel and more effective interventions that map onto core pathological processes underlying the CHR-P features<sup><xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR6">6</xref></sup>. Mind-reading, i.e., the ability to infer others’ mental states, is integral for social interactions<sup><xref ref-type="bibr" rid="CR7">7</xref></sup> and impaired in early psychosis patients<sup><xref ref-type="bibr" rid="CR8">8</xref></sup> and CHR-P subjects<sup><xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR10">10</xref></sup>. Mental state attribution or perspective taking is a complex multidimensional construct and involves the ability to infer the thoughts or beliefs of others (i.e. cognitive empathy), but also the ability to infer the emotions or feelings of others (i.e. emotional empathy)<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>. Past evidence showed that cognitive and emotional aspects of empathy are partly dissociable systems<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>. While neurocognitive dysfunction significantly accounts for impairments during theory of mind (ToM) tasks in CHR-P individuals<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>, they still remain evident after adjusting for deficits in neurocognition<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>, indicating the crucial contribution of impaired emotional empathy to ToM deficits in CHR-P. Meta-analytical evidence identified the left anterior midcingulate cortex/dorsal anterior cingulate cortex, bilateral insula/inferior frontal gyrus and bilateral supplementary motor area as being consistently activated in empathy<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>. While the bilateral anterior insula/inferior frontal gyrus is specifically activated during emotional empathy, activation in the left midcingulate cortex and left anterior insula is more related to the cognitive aspect of empathy<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>. Previous functional magnetic resonance imaging (fMRI) studies in CHR-P individuals reported increased activation in the prefrontal cortex including the inferior frontal gyrus, posterior cingulate cortex and the temporoparietal cortex during inferring others’ mental status relative to healthy controls, suggesting a compensatory overactivation of brain regions critical for empathic responses during mental state attribution<sup><xref ref-type="bibr" rid="CR14">14</xref>,<xref ref-type="bibr" rid="CR15">15</xref></sup>. Another study observed reduced bilateral inferior frontal gyrus activation during inferring others’ emotions but not beliefs in CHR-P subjects relative to healthy subjects<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>.</p>
              <p id="Par3">Given its critical role in human social behaviour and cognition<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>, the oxytocinergic (OT) system is a promising target for the treatment of social impairments in CHR-P subjects. OT has been proposed to be a key neural substrate that interacts with central dopamine systems<sup><xref ref-type="bibr" rid="CR18">18</xref></sup> and may counteract hyperdopaminergia seen in psychosis<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>. Previous studies have reported altered blood OT levels in schizophrenia patients<sup><xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR21">21</xref></sup>, which predicted social cue recognition<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>. CHR-P individuals show significantly decreased OT receptor gene methylation, which was related to increased anhedonia-asociality<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>. OT administration improves mind-reading<sup><xref ref-type="bibr" rid="CR23">23</xref></sup> and trust<sup><xref ref-type="bibr" rid="CR24">24</xref></sup> in healthy volunteers. Notably, OT affects emotional rather than cognitive empathy in healthy people<sup><xref ref-type="bibr" rid="CR25">25</xref></sup> and its effect on mind-reading depends on baseline social-emotional abilities<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. A single dose of OT also improves emotion recognition<sup><xref ref-type="bibr" rid="CR27">27</xref>–<xref ref-type="bibr" rid="CR29">29</xref></sup>, higher-order social cognition (such as appreciation of indirect hints and recognition of social faux pas<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>), as well as working memory<sup><xref ref-type="bibr" rid="CR31">31</xref></sup> in schizophrenia patients. However, evidence for OT effects on cognitive and emotional empathy in early psychosis is sparse. A first study showed that 24 IU for 6 weeks did not improve cognitive empathy in individuals with early schizophrenia-spectrum psychotic illness<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>.</p>
              <p id="Par4">This study investigated, for the first time, whether acute OT administration changed the ability to successfully infer on others people’s beliefs (cognitive empathy) and social emotions (emotional empathy) in CHR-P males, and whether this change goes along with altered neural activation. Based on previous evidence in healthy people<sup><xref ref-type="bibr" rid="CR25">25</xref>,<xref ref-type="bibr" rid="CR33">33</xref></sup> and CHR-P individuals<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>, we expected that OT would enhance successful recognition of others’ facial emotions but not beliefs and that this improvement in successful social emotion inferences would be accompanied by increased neural activation in the emotional empathy network, in particular in the inferior frontal gyrus. As previously shown<sup><xref ref-type="bibr" rid="CR26">26</xref>,<xref ref-type="bibr" rid="CR34">34</xref></sup>, we further predicted that OT effects would be moderated by baseline social-emotional abilities, with CHR-P individuals low in social-emotional abilities showing greater improvements after OT administration.</p>
            </sec>
            <sec id="Sec2" sec-type="materials|methods">
              <title>Materials and methods</title>
              <sec id="Sec3">
                <title>Participants</title>
                <p id="Par5">The study received National Research Ethics Service approval (14/LO/1692) and all subjects gave written informed consent. The participants and OT administration have previously been described in our Arterial Spin Labelling (ASL)<sup><xref ref-type="bibr" rid="CR35">35</xref></sup> and magnetic resonance spectroscopy (<sup>1</sup>H-MRS)<sup><xref ref-type="bibr" rid="CR36">36</xref></sup> studies. Sample size was estimated using G*Power 3 to detect neurochemical effects based on a previous <sup>1</sup>H-MRS study<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>, which indicated that a sample size of 30 was sufficient to detect a medium within-subject effect size (<italic>d</italic><sub><italic>z</italic></sub> = 0.53), when alpha=0.05 and power=80%. Thirty male, help-seeking CHR-P individuals aged 18–35 were recruited from two specialist early detection services—the OASIS<sup><xref ref-type="bibr" rid="CR38">38</xref></sup> and Tower Hamlets Early Detection Service (THEDS), which belongs to the Pan-London Network for Psychosis-prevention (PNP)<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>. CHR-P status was assessed using the Comprehensive Assessment of At-Risk Mental States (CAARMS) 12/2006 criteria<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>. In brief, subjects met one or more of the following subgroup criteria: (a) attenuated psychotic symptoms, (b) brief limited intermittent psychotic symptoms (BLIPS, psychotic episode lasting &lt;1 week, remitting without treatment<sup><xref ref-type="bibr" rid="CR41">41</xref>–<xref ref-type="bibr" rid="CR43">43</xref></sup>), or (c) either schizotypal personality disorder or first-degree relative with psychosis<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>, all coupled with functional decline. Individuals were excluded if there was a history of previous psychotic disorder (with the exception of BLIPS, some of whom may meet Acute and Transient Psychotic Disorder criteria<sup><xref ref-type="bibr" rid="CR42">42</xref></sup>) or manic episode, exposure to antipsychotics, neurological disorder or current substance-use disorder, estimated IQ &lt; 70, acute intoxication on the day of scanning, and any contraindications to MRI or intranasal OT or placebo. History of Axis I disorder(s) was not an exclusion criterion due to the transdiagnostic nature of the CAARMS-based definition of the CHR-P state<sup><xref ref-type="bibr" rid="CR44">44</xref></sup> and the high prevalence of such diagnoses within these populations<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>. We also collected information on medication history, alcohol (Alcohol Use Disorders Identification Test), tobacco and cannabis use, functioning (Global Functioning Role and Social scales<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>) and transition status. One subject reported cannabis use prior to one scan and was therefore excluded from analysis. Furthermore, to test for potential moderation effects of baseline social-emotional abilities on OT effects<sup><xref ref-type="bibr" rid="CR26">26</xref>,<xref ref-type="bibr" rid="CR47">47</xref></sup>, the Reading the Mind in the Eyes Test (RMET<sup><xref ref-type="bibr" rid="CR48">48</xref></sup>) was acquired prior to the first scan. RMET measures the ability to interpret subtle social-emotional cues from the eye region<sup><xref ref-type="bibr" rid="CR48">48</xref></sup>. It compromised 36 photographs depicting the eye region of Caucasian posers. Stimuli were presented on a black background in the center of a computer screen. In the four corners around the picture, one target label and three distractors were simultaneously shown. Participants were asked to select the correct mental state as fast as possible. The picture remained on the screen until participants clicked on a label with the mouse. A practice trial was conducted, and a glossary was provided in paper form. Performance was determined by calculating the percentage of correct answers. Demographic and clinical characteristics of the sample are presented in Table <xref rid="Tab1" ref-type="table">1</xref>.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Participant demographic and clinical characteristics.</p></caption><table frame="hsides" rules="groups"><tbody><tr><td>Demographic</td><td/></tr><tr><td> Age years; mean (SD)</td><td>22.48 (4.68)</td></tr><tr><td> Age range. years</td><td>18–34</td></tr><tr><td> Sex; male/female</td><td>30/0</td></tr><tr><td> Ethnicity (White/Black/Asian/Mixed)</td><td>15/5/3/4</td></tr><tr><td> Handedness. right/left</td><td>23/4</td></tr><tr><td> Education. years; mean (SD)</td><td>13.33 (1.9)</td></tr><tr><td>Clinical</td><td/></tr><tr><td> CHR-P Subtype<sup>a</sup> (BLIPS/APS/GRD)</td><td>5/21/1</td></tr><tr><td> CAARMS attenuated positive symptoms<sup>b</sup>; mean (SD)</td><td>11.85 (3.44)</td></tr><tr><td> Baseline anxiety score<sup>c</sup>; mean (SD)</td><td>35.07 (9.83)</td></tr><tr><td> GF social score; mean (SD)</td><td>6.85 (1.46)</td></tr><tr><td> GF role score; mean (SD)</td><td>7.04 (1.63)</td></tr><tr><td> RMET<sup>d</sup>; mean (SD), median</td><td>25.38 (4.99), 26</td></tr><tr><td>Substance Use</td><td/></tr><tr><td> Current antidepressant medication (yes/no)<sup>e</sup></td><td>8/19</td></tr><tr><td> Current antipsychotic medication (yes/no)</td><td>0/27</td></tr><tr><td> Current benzodiazepine medication (yes/no)</td><td>0 / 27</td></tr><tr><td> Current smoker (yes/no)</td><td>15/12</td></tr><tr><td> Cigarettes/day; mean (SD)</td><td>9.33 (6.29)</td></tr><tr><td> Cannabis use<sup>f</sup>; median (range)</td><td>2 (0–4)</td></tr><tr><td> Alcohol. AUDIT total; mean (SD)</td><td>6.74 (7.22)</td></tr></tbody></table><table-wrap-foot><p><italic>AUDIT</italic> alcohol use disorders identification test, <italic>CHR-P</italic> clinical high risk for psychosis, <italic>GF</italic> global functioning (role and social) scale.</p><p><sup>a</sup>Comprehensive Assessment of At-Risk Mental States (CAARMS) subgroup; <italic>BLIPS</italic> brief limited intermittent psychotic symptoms, <italic>APS</italic> attenuated psychotic symptoms, <italic>GRD</italic> genetic risk and deterioration.</p><p><sup>b</sup>Sum of the global (severity) ratings for positive subscale items (P1-P4) of the CAARMS.</p><p><sup>c</sup>Mean of pre-scan anxiety scores across conditions as measured by the State Trait Anxiety Inventory (STAI).</p><p><sup>d</sup>Reading the Mind in the Eyes Test (RMET) score at the initial clinical assessment.</p><p><sup>e</sup>Three subjects received Sertraline (20 mg, 25 mg and 100 mg), one Escitalopram (20 mg), one Mirtazapine (30 mg), one Amitriptyline (10 mg), one Fluexetine (40 mg) and one received 300 mg of unknown type.</p><p><sup>f</sup>Cannabis use: 0 = never, 1 = experimental use (tried occasionally), 2 = occasional use (small quantities from time to time), 3 = moderate use (moderate quantities regularly/large amounts occasionally), 4 = severe use (frequently used large quantities, often to intoxication/debilitation).</p></table-wrap-foot></table-wrap></p>
              </sec>
              <sec id="Sec4">
                <title>Study design</title>
                <p id="Par6">Using a randomised, double-blind, crossover design, 40 IU intranasal OT and placebo were administered in a counterbalanced fashion with a 1-week wash out period. During each challenge, subjects underwent an MRI scan which started at 11:30 h to minimise potential effects of diurnal variation in OT or vasopressin<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>. Intranasal OT administration followed recommended guidelines and a protocol adopted by a previous study conducted at our institute<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>. As done in our previous studies<sup><xref ref-type="bibr" rid="CR35">35</xref>,<xref ref-type="bibr" rid="CR36">36</xref></sup>, participants self-administered one puff (4 IU) of intranasal OT or matched placebo every 30 s, alternating between nostrils, until 40 IU had been administered. See refs. <sup><xref ref-type="bibr" rid="CR35">35</xref>,<xref ref-type="bibr" rid="CR36">36</xref></sup> for more details.</p>
              </sec>
              <sec id="Sec5">
                <title>Functional MRI paradigm</title>
                <p id="Par7">A modified version of the Sally-Anne task was used as previously applied in individuals with autism spectrum disorder after OT administration<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>. Participants underwent two runs consecutively, each of which lasted approximately 7.5 min. Each run consisted of 10 different stories (Supplementary Fig. <xref rid="MOESM1" ref-type="media">1</xref>), while every story was presented three times in a row, one for each of the three conditions: ‘control', ‘belief inference (cognitive empathy)' and ‘social emotion inference (emotional empathy)'. The identical set of 10 stories was presented during the first and second run. At the end of each story participants were required to answer ‘yes–no’. Questions were presented in a pseudorandom fashion, so that ‘yes’ questions in the first run were modified to be ‘no’ questions in the second run, and vice versa. Before scanning, all participants were shown the cartoon stories in a mock scanner and required to answer questions as in the ‘control’ condition. In this manner, participants were trained to grasp the stories without experiencing the questions of the ‘Belief’ and ‘Social emotion’ conditions.</p>
                <p id="Par8">Let us take one story as an example. As summarized in Fig. <xref rid="Fig1" ref-type="fig">1a</xref>, four frames show a story with two persons with neutral faces. During the story, one person (Sally) places a ball in a left box (Frame 1) and leaves the room (Frame 2). Meanwhile, another person (Anne) moves the ball to a right box (Frame 3) and then Sally returns (Frame 4). At the end of the story, participants are asked the following three types of questions in a pseudorandom order (Fig. <xref rid="Fig1" ref-type="fig">1b</xref>): ‘Is the ball actually in this box? (indicating a left box with a star)’ for the control condition, ‘Does she look for her ball in this box? (indicating Sally with an arrow and a left box by a star)’ for the belief inference condition, and ‘Does she feel playful, seeing the box opened?’ for the social emotion inference condition. To answer the first question (control condition), participants are required to understand the actual location of the ball. For the second question (belief inference), they are required to understand that Sally’s actions will be based on what she believes to be true, rather than the actual location. In the third question (social emotion inference), participants were required to answer the question about Anne’s emotional status after she completed the practical joke. To successfully infer on Anne’s emotional status, it is required not only to understand the story (control condition) but also that Anne believes that Sally falsely believes the ball is in the left box. In other words, successful social emotion inference (emotional empathy) depended on successful belief inference (cognitive empathy) but not vice versa. Task conditions and trial timing are summarized in Fig. <xref rid="Fig1" ref-type="fig">1c</xref>. Each trial consisted of 3.5 s story presentation with four frames (see Fig. <xref rid="Fig1" ref-type="fig">1a</xref>); 2 s question; 2.5–3.5 s fixation cross; 3 s of a frame with comic vignette that illustrates an arrow and a star to help to answer the question; and 3 s fixation cross. Participants were required to answer this question during the last frame with comic and fixation cross by pressing a button to answer yes or no.<fig id="Fig1"><label>Fig. 1</label><caption><title>Task design.</title><p><bold>a</bold> Each story consisted of four frames with two people. There are 10 different types of stories (see supplementary Fig. <xref rid="MOESM1" ref-type="media">1</xref>). <bold>b</bold> Each story was presented three times consecutively per each run. At the end of each story presentation, participants were asked to answer the following three types of questions that asked emotion of the character, belief of the character, and fact (control condition). These three questions appeared in a pseudorandom order, followed by an answer frame. <bold>c</bold> Trial timing. 3.5 s story presentation with four frames of a black and white comic. Then, a frame with a question written in white letters on the black screen was shown for 2 s. After 2.5–3.5 s white fixation cross on the black screen, another frame was presented to illustrate an arrow and a star to help to answer the question (3 s). At the end of one story, a 3-s fixation cross was shown. During the last frame and fixation cross, participants were instructed to answer the question with yes or no.</p></caption><graphic xlink:href="41398_2020_885_Fig1_HTML" id="d30e1069"/></fig></p>
              </sec>
              <sec id="Sec6">
                <title>Behavioural analysis</title>
                <p id="Par9">We measured accuracy and reaction time to correct responses during the task. Paired t-test was used to test OT effects for each task condition.</p>
              </sec>
              <sec id="Sec7">
                <title>Image acquisition and processing</title>
                <p id="Par10">All scans were conducted on a General Electric Discovery MR750 3 Tesla system (General Electric, Chicago, USA) using a 32-channel head coil. During the task, we acquired T2*-weighted echo-planar images with the following parameters: 41 axial slices of 3 mm thickness, 0.3 mm interslice gap, field of view 24 × 24 cm<sup>2</sup> and flip angle 75°. The repetition time was 2 s and the echo time 30 ms. EPIs were analysed using an event-related design with SPM12 (<ext-link ext-link-type="uri" xlink:href="http://www.fil.ion.ucl.ac.uk/spm">www.fil.ion.ucl.ac.uk/spm</ext-link>). Pre-processing was performed for each subject and time point separately. In brief, slice-timing correction was first performed on each volume using the middle slice as the reference to adjust for time differences due to multislice image acquisition. The images were then realigned to the first image in the series. The anatomical T1 image was co-registered with the first functional image and then spatially normalized into the MNI space, generating normalization parameters, which were applied to all functional images. Functional images were smoothed with a Gaussian kernel of 8 mm full half-width maximum (FWHM). All images were checked for movement artefacts and subjects with more than 10% corrupted volumes (all scans with more than 3 mm deviation from the previous scan in any dimension) were excluded (one subject). Voxel-wise maximum likelihood parameter estimates were calculated during the first-level analysis using the general linear model. Our design matrix included an autoregressive AR(1) model of serial correlations and a high-pass filter with a cut-off of 128 s. The onsets of each event were convolved with the SPM synthetic haemodynamic response function. Each event-related regressor had an onset at the time of the answer frame and a duration that correspond to each response time (see Fig. <xref rid="Fig1" ref-type="fig">1c</xref>). First-level models were constructed for both treatments separately, including only the onset times for correct responses in the control, belief and social emotion condition during both runs. In line with previous studies using the same task<sup><xref ref-type="bibr" rid="CR16">16</xref>,<xref ref-type="bibr" rid="CR50">50</xref></sup>, this approach allowed us to study whether OT administration changed neural activation while successfully inferring others’ belief and social emotion relative to placebo. One subject had no correct responses during one of the four runs and was therefore excluded. The final sample thus consisted of 27 subjects. Two contrast images were generated per participant: ‘belief &gt; control’ (cognitive empathy) and ‘social emotion &gt; control’ (emotional empathy). One-sample t tests were conducted to test for effects of condition (cognitive and emotional empathy) after placebo administration and paired t-tests were conducted to test for treatment effects in the two interrelated contrasts of interest separately as previously done<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>. Significance was assessed at a cluster-level threshold of <italic>p</italic> &lt; 0.05 family-wise error (FWE) corrected across the whole brain with an uncorrected cluster-forming threshold of <italic>p</italic> &lt; 0.001<sup><xref ref-type="bibr" rid="CR51">51</xref>,<xref ref-type="bibr" rid="CR52">52</xref></sup> with an extent threshold of 20 voxels.</p>
              </sec>
              <sec id="Sec8">
                <title>Impact of baseline social-emotional abilities</title>
                <p id="Par11">The relationship between baseline social-emotional ability (RMET performance) and significant brain effect (left inferior frontal gyrus) after OT administration was tested using Spearman correlation at a significance level of <italic>p</italic> &lt; 0.05. Parameter estimates were extracted from the whole left inferior frontal gyrus cluster (300 voxels) showing a significant effect between OT and placebo during inferring others’ social emotions (‘social emotion &gt; control’ contrast). Nonparameteric correlation was performed due to the fact that parameter estimates of left inferior frontal gyrus activation were not normally distributed as indicated by a significant Kolmogorov–Smirnov test (<italic>p</italic> = 0.033). We further used a linear regression to test whether the relationship between brain activation in left inferior frontal gyrus and task accuracy after OT administration was moderated by RMET performance. Task accuracy was entered as dependent variable and the interaction RMET x left inferior frontal gyrus activation as independent variable. To perform a parametric moderator analysis, parameter estimates in the left inferior frontal gyrus after OT administration were first log transformed.</p>
              </sec>
            </sec>
            <sec id="Sec9" sec-type="results">
              <title>Results</title>
              <sec id="Sec10">
                <title>Behavioural task performance</title>
                <p id="Par12">OT did not modulate accuracy for the control (<italic>T</italic> = 0.332, <italic>p</italic> = 0.743), belief (<italic>T</italic> = 0.618, <italic>p</italic> = 0.542) or social (<italic>T</italic> = 0.775, <italic>p</italic> = 0.445) condition (Fig. <xref rid="Fig2" ref-type="fig">2a</xref>). OT also did not influence reaction times for correct responses during the control (<italic>T</italic> = 0.024, <italic>p</italic> = 0.981), belief (<italic>T</italic> = 0.801, <italic>p</italic> = 0.430) or social (<italic>T</italic> = 1.11, <italic>p</italic> = 0.277) condition (Fig. <xref rid="Fig2" ref-type="fig">2b</xref>). Correlations between reaction time and accuracy within and between the different task conditions are presented in Supplementary Table <xref rid="MOESM1" ref-type="media">1</xref>.<fig id="Fig2"><label>Fig. 2</label><caption><title>Behavioral task performance.</title><p>Accuracies and reaction times in response to correct responses for both treatments during the task.</p></caption><graphic xlink:href="41398_2020_885_Fig2_HTML" id="d30e1192"/></fig></p>
              </sec>
              <sec id="Sec11">
                <title>Brain activation</title>
                <sec id="Sec12">
                  <title>Effect of conditions</title>
                  <p id="Par13">Inferring others’ beliefs (belief &gt; control) evoked significant activation in left precuneus, angular gyrus, inferior frontal and parietal gyrus and bilateral middle frontal gyrus (Supplementary Table <xref rid="MOESM1" ref-type="media">2</xref>, Supplementary Fig. <xref rid="MOESM1" ref-type="media">2A</xref>). Inferring others’ social emotions (social emotion &gt; control) evoked significant activation in left supplementary motor area, superior frontal gyrus, inferior temporal gyrus, angular gyrus, precuneus, right cerebellum, and bilateral inferior and middle frontal gyrus, middle temporal gyrus and caudate (Supplementary Table <xref rid="MOESM1" ref-type="media">3</xref>, Supplementary Fig. <xref rid="MOESM1" ref-type="media">2B</xref>).</p>
                </sec>
                <sec id="Sec13">
                  <title>Effect of OT</title>
                  <p id="Par14">OT did not modulate brain activation during inferring others’ beliefs relative to placebo (Supplementary Table <xref rid="MOESM1" ref-type="media">4</xref>). However, during inferring others’ social emotions, OT significantly reduced activation in the left and right inferior frontal gyrus (Table <xref rid="Tab2" ref-type="table">2</xref>, Fig. <xref rid="Fig3" ref-type="fig">3a</xref>). No significantly increased activation was found after OT relative to the placebo adiminstration during inferring others’ social emotions (Supplementary Table <xref rid="MOESM1" ref-type="media">5</xref>). Notably, the differences in left (<italic>T</italic> = 0.156, <italic>p</italic> = 0.879) and right (<italic>T</italic> = 0.873, <italic>p</italic> = 0.419) inferior frontal gyrus activation after OT relative to placebo did not differ between those individuals who received antidepressants (<italic>n</italic> = 8) or not.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Treatments effects (placebo &gt; OT) during inferring others’ social emotion (‘social emotion &gt; control’).</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Region, hemisphere</th><th>pFWE, cluster-level</th><th>Cluster size pFWE</th><th><italic>T</italic> value</th><th><italic>Z</italic> value</th><th colspan="3">MNI coordinates (<italic>x</italic>/<italic>y</italic>/<italic>z</italic>)</th></tr></thead><tbody><tr><td>Inferior Frontal Gyrus, L</td><td>0.039</td><td>300</td><td>6.05</td><td>4.63</td><td>−48</td><td>18</td><td>−4</td></tr><tr><td>Inferior Frontal Gyrus, L</td><td/><td/><td>5.26</td><td>4.22</td><td>−30</td><td>36</td><td>−8</td></tr><tr><td>Inferior Frontal Gyrus, L</td><td/><td/><td>4.69</td><td>3.89</td><td>−56</td><td>16</td><td>2</td></tr><tr><td>Inferior Frontal Gyrus, R</td><td>0.042</td><td>294</td><td>5.52</td><td>4.36</td><td>48</td><td>26</td><td>−4</td></tr><tr><td>Inferior Frontal Gyrus, R</td><td/><td/><td>4.99</td><td>4.07</td><td>32</td><td>34</td><td>−8</td></tr><tr><td>Parahippocampus, R</td><td>0.563</td><td>71</td><td>4.68</td><td>3.88</td><td>30</td><td>−10</td><td>−28</td></tr><tr><td>Hippocampus, R</td><td/><td/><td>4.00</td><td>3.45</td><td>20</td><td>−10</td><td>−16</td></tr><tr><td>Middle temporal gyrus, R</td><td>0.099</td><td>216</td><td>4.65</td><td>3.87</td><td>58</td><td>−42</td><td>−4</td></tr><tr><td>Middle temporal gyrus, R</td><td/><td/><td>4.30</td><td>3.65</td><td>66</td><td>−36</td><td>−2</td></tr><tr><td>Inferior temporal gyrus, R</td><td/><td/><td>3.68</td><td>3.23</td><td>64</td><td>−44</td><td>−10</td></tr><tr><td>Postcentral gyrus, R</td><td>0.200</td><td>157</td><td>4.16</td><td>3.56</td><td>42</td><td>−22</td><td>34</td></tr><tr><td>Postcentral gyrus, R</td><td/><td/><td>3.93</td><td>3.40</td><td>36</td><td>−26</td><td>42</td></tr><tr><td>Postcentral gyrus, R</td><td/><td/><td>3.75</td><td>3.28</td><td>42</td><td>−28</td><td>58</td></tr><tr><td>Middle temporal gyrus, L</td><td>0.742</td><td>45</td><td>4.14</td><td>3.54</td><td>−60</td><td>−38</td><td>6</td></tr><tr><td>Calcarine, L</td><td>0.778</td><td>40</td><td>4.09</td><td>3.51</td><td>−26</td><td>−70</td><td>8</td></tr><tr><td>Calcarine, L</td><td/><td/><td>4.00</td><td>3.45</td><td>−24</td><td>−62</td><td>12</td></tr><tr><td>Putamen, L</td><td>0.854</td><td>29</td><td>4.08</td><td>3.50</td><td>−34</td><td>−10</td><td>−4</td></tr><tr><td>Parahippocampus, R</td><td>0.841</td><td>31</td><td>4.07</td><td>3.50</td><td>12</td><td>−22</td><td>−12</td></tr><tr><td>Cerebellum, L</td><td>0.899</td><td>22</td><td>3.95</td><td>3.42</td><td>−8</td><td>−42</td><td>−22</td></tr></tbody></table><table-wrap-foot><p><italic>FWE</italic> family-wise error.</p></table-wrap-foot></table-wrap><fig id="Fig3"><label>Fig. 3</label><caption><title>Imaging results.</title><p><bold>a</bold> Significant reduced activation in the left and right inferior frontal gyrus (IFG) during inferring others’ social emotion (social emotion &gt; control) after OT compared with the placebo administration. Images are displayed at a cluster-forming threshold of <italic>p</italic>&lt;0.001 uncorrected, with an extent threshold of 20 voxels. Colour bars indicate <italic>t</italic> values. <bold>b</bold> Significant correlation between left IFG activation after OT administration (i.e. parameter estimate, PE) during inferring others’ social emotion and baseline RMET performance (<italic>r</italic>=0.388, <italic>p</italic>=0.046). <bold>c</bold> Moderator effect of baseline RMET performance on the relationship between left IFG activation after OT administration (i.e. parameter estimate, PE) and task accuracy during inferring others’ social emotions after OT administration.</p></caption><graphic xlink:href="41398_2020_885_Fig3_HTML" id="d30e1772"/></fig></p>
                </sec>
              </sec>
              <sec id="Sec14">
                <title>Moderater effect of baseline social-emotional abilities on OT effects</title>
                <p id="Par15">We further tested whether left inferior frontal gyrus activation after OT administration during inferring others’ social emotions (social emotion &gt; control) was related to baseline RMET scores. There was a significant positive correlation between baseline RMET scores and left inferior frontal gyrus activation after OT administration (<italic>r</italic> = 0.388, <italic>p</italic> = 0.046) (Fig. <xref rid="Fig3" ref-type="fig">3b</xref>). We further found that RMET score also moderated the relationship between left frontal gyrus activation during inferring others’ social emotion and task accuracy after OT administration, as indicatined by a significant interaction RMET × left inferior frontal gyrus (β=−3.53, <italic>p</italic> = 0.020). The moderator effect was also evident after median (median = 26) splitting the sample into high (<italic>n</italic> = 13) and low (<italic>n</italic> = 14) RMET performance (β=−20.05, <italic>p</italic> = 0.023). While task accuracy increased with decreasing activation in the left inferior frontal gyrus in CHR-P individual with low RMET scores (<italic>r</italic> = −0.578, <italic>p</italic> = 0.030), there was no significant relationship between task accuracy and left inferior frontal gyrus activation in CHR-P individual with high RMET scores (<italic>r</italic> = 0.088, <italic>p</italic> = 0.775) (Fig. <xref rid="Fig3" ref-type="fig">3c</xref>).</p>
              </sec>
            </sec>
            <sec id="Sec15" sec-type="discussion">
              <title>Discussion</title>
              <p id="Par16">To the best of our knowledge, this is the first fMRI study to assess how acute OT administration modulated brain activation during inferring others’ beliefs and social emotions in CHR-P individuals. The first main finding is that OT did not affect brain responses during belief inference (cognitive empathy) but reduced activation in the bilateral inferior frontal gyrus during social emotion inference (emotional empathy). The second main finding is that neural activation in the left inferior frontal gyrus during social emotion inference after OT administration was modulated by baseline social-emotional abilities, which also moderated the relationship between brain activation and task performance. These findings can inform subsequent experimental therapeutics in this patient population.</p>
              <p id="Par17">The first finding of this study is that while OT did not modulate neural responses during belief inference it did reduce neural activation in the bilateral inferior frontal gyrus during social emotion inference. OT has been shown to enhance emotional but not cognitive empathy in healthy participants<sup><xref ref-type="bibr" rid="CR25">25</xref>,<xref ref-type="bibr" rid="CR33">33</xref></sup>, an effect that could be replicated across culture and sex<sup><xref ref-type="bibr" rid="CR53">53</xref></sup>. In early psychosis patients, OT treatment did not enhance cognitive empathy but improved the ability to recognize emotions in schizophrenia patients<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>. We add to this line of evidence by showing that OT significantly decreased activation in the bilateral inferior frontal gyrus during emotional but not cognitive empathy in CHR-P subjects. The inferior frontal gyrus has been increasingly implicated in emotion recognition tasks such as identification of emotional intonation<sup><xref ref-type="bibr" rid="CR54">54</xref></sup>, judgment of facial expressions<sup><xref ref-type="bibr" rid="CR55">55</xref></sup> and is an essential part of the neural mirror system, which is involved in a variety of important social behaviours, from imitation to emotional empathy<sup><xref ref-type="bibr" rid="CR56">56</xref></sup>. Good imitation facilitates recognizing emotions in other people and thus emotional empathy<sup><xref ref-type="bibr" rid="CR57">57</xref></sup>. Previous seminal work demonstrated that patients with inferior frontal gyrus lesions displayed extremely impaired emotional but not cognitive empathy<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>. More importantly, a previous study that used the same fMRI task in CHR-P found reduced activation in the bilateral inferior frontal gyrus when inferring others emotions but not beliefs relative to healthy controls<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>. The inferior frontal gyrus is a core target of the neurofunctional effects of OT<sup><xref ref-type="bibr" rid="CR58">58</xref></sup>. OT may promote assimilation of novel emotional experiences into internal models<sup><xref ref-type="bibr" rid="CR59">59</xref></sup>, which is supported by parts of the left inferior frontal gyrus<sup><xref ref-type="bibr" rid="CR60">60</xref></sup>. Emotion perception is impaired in patients with schizophrenia<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>, CHR-P subjects<sup><xref ref-type="bibr" rid="CR61">61</xref></sup>, offspring of parents with schizophrenia<sup><xref ref-type="bibr" rid="CR62">62</xref></sup> and is related to poor functional outcomes<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR61">61</xref></sup>. As a potential compensatory mechanism for this deficit, stronger inferior frontal gyrus activation during emotional perspective taking has been observed in CHR-P subjects compared with healthy controls<sup><xref ref-type="bibr" rid="CR14">14</xref>,<xref ref-type="bibr" rid="CR15">15</xref></sup>. Given that task performance during emotional empathy did not differ between OT and placebo in the current study, decreased inferior frontal gyrus activation after OT administration might indicate enhanced neural efficiency. Such an interpretation corresponds with a recent study showing that OT enhances neural efficiency of social perception as expressed by reduced event-related potential latencies<sup><xref ref-type="bibr" rid="CR63">63</xref></sup>. Taken together, we might speculate that after receiving placebo, CHR-P subjects compensated their deficits in emotional perspective-taking by increasing activation in the inferior frontal gyrus compared with healthy individuals, as previously shown<sup><xref ref-type="bibr" rid="CR14">14</xref>,<xref ref-type="bibr" rid="CR15">15</xref></sup>, whereas OT may enhance neural efficiency in the inferior frontal gyrus by normalizing activation to the level of healthy persons.</p>
              <p id="Par18">The second main finding was of a positive relationship between baseline social-emotional abilities and left inferior frontal gyrus activation during social emotion inference (emotional empathy) after OT administration. Moreover, baseline social-emotional abilities as expressed by RMET performance moderated the relationship between OT-induced task performance and inferior frontal gyrus activation during emotional empathy. In particular, whereas inferior frontal gyrus activation decreased with increasing task performance in CHR-P subjects with low baseline social-emotional abilities, no such relationship was found in CHR-P subjects with high baseline social-emotional abilities. These findings suggest that OT-induced improvement in neural efficiency as expressed by decreased activation in the inferior frontal gyrus only took place in those CHR-P subjects with low baseline social-emotional abilities. In other words, CHR-P subjects with low social-emotional abilities needed less activation in the inferior frontal gyrus to achieve comparable task performance as after placebo administration. This finding resonates with previous reports demonstrating that OT selectively improved mind-reading as assessed with the RMET in those individuals with low emotional empathy<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>, high in alexithymia or high in maternal love withdrawal<sup><xref ref-type="bibr" rid="CR34">34</xref>,<xref ref-type="bibr" rid="CR64">64</xref>,<xref ref-type="bibr" rid="CR65">65</xref></sup>. Although RMET performance has mostly been associated with cognitive empathy<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>, a recent study demonstrated that the RMET measures emotion recognition rather than theory of mind (i.e. cognitive empathy) ability<sup><xref ref-type="bibr" rid="CR66">66</xref></sup>. Taken together, there is emerging evidence that OT influences emotional rather than cognitive processing and that its benefit depends on emotional empathy capacity.</p>
              <p id="Par19">There are several possible clinical implications. The dearth of preventive treatments that can effectively impact clinical outcomes—in particular social functioning deficits— can be partially explained by lack of clear aetiopathological mechanisms underlying the therapeutic effects of preventive agents. This study advances knowledge in this area by providing the first disease target-engagement evidence in CHR-P individuals. These neurophysiological results can inform the development of subsequent randomised controlled trials investigating OT’s effects on CHR-P symptoms and on clinical outcomes. Identifying novel therapeutic target for outcomes other than psychosis onset is a mainstream of future research in this area, considering that most CHR-P individuals who will not transition to psychosis will still display social functioning deficits at follow-up<sup><xref ref-type="bibr" rid="CR67">67</xref></sup>.</p>
              <p id="Par20">The present study has limitations. No healthy control group was included in the current study. However, we have used a fMRI task which was already tested in CHR-P vs. healthy controls<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>, demonstrating significant alterations in key brain areas that are also implicated in this study. Due to sex differences in brain responses to OT during social interaction<sup><xref ref-type="bibr" rid="CR68">68</xref></sup>, only male subjects were included. Another limitation is that this study did not collect extensive data on negative symptoms or neurocognition. Dose-response assessments are further required to test whether lower dosing might be sufficient for optimal target engagement, i.e. improving neural efficiency in the inferior frontal gyrus. While this study demonstrated that acute OT administration modulates key brain regions during inferring others’ social emotions, OT effects on functional outcomes in CHR-P subjects need to be tested in future longer-term clinical trials. Furthermore, in terms of the neurophysiological mechanisms by which OT has its effects, we previously reported that OT modulates cerebral (hippocampal) perfusion in CHR-P patients<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>, but did not appear to modulate regional concentrations of neurochemical metabolites<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>. The mechanisms by which OT increases neural efficiency in CHR-P individuals therefore warrants further research. A final limitation is that because of the small sample size we have been unable to stratify the heterogeneous CHR-P group across its three main subgroups<sup><xref ref-type="bibr" rid="CR69">69</xref></sup>.</p>
              <p id="Par21">In conclusion, the present study provides the first evidence that acute OT administration modulates brain regions while inferring others’ social emotions in CHR-P subjects. Abnormal emotion perception persists over the course of the illness<sup><xref ref-type="bibr" rid="CR70">70</xref></sup> and is predictive for poor functional outcomes in CHR-P subjects<sup><xref ref-type="bibr" rid="CR61">61</xref></sup>. This study may thus provide neural targets to develop novel treatments for socio-emotional deficits in CHR-P subjects with the aim to improve functional outcomes.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supplementary information</title>
              <sec id="Sec16">
                <p>
                  <supplementary-material content-type="local-data" id="MOESM1">
                    <media xlink:href="41398_2020_885_MOESM1_ESM.docx">
                      <caption>
                        <p>Supplementary Information</p>
                      </caption>
                    </media>
                  </supplementary-material>
                </p>
              </sec>
            </sec>
          </body>
          <back>
            <fn-group>
              <fn>
                <p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
              </fn>
            </fn-group>
            <sec>
              <title>Supplementary information</title>
              <p><bold>Supplementary Information</bold> accompanies this paper at (10.1038/s41398-020-00885-4).</p>
            </sec>
            <ack>
              <title>Acknowledgements</title>
              <p>This work was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at South London and Maudsley NHS Foundation Trust and King’s College London (P.F.P., P.M.); by a Brain &amp; Behaviour Research Foundation NARSAD Award (grant number 22593 to P.F.P.); and by the Department of Psychosis Studies, Institute of Psychiatry, Psychology &amp; Neuroscience, King’s College London. D.O. is supported by the UK Medical Research Council (MR/N013700/1) and is a King’s College London member of the MRC Doctoral Training Partnership in Biomedical Sciences.</p>
            </ack>
            <notes id="FPar1" notes-type="COI-statement">
              <title>Conflict of interest</title>
              <p id="Par22">The authors declare that they have no conflict of interest.</p>
            </notes>
            <ref-list id="Bib1">
              <title>References</title>
              <ref id="CR1">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Couture</surname>
                      <given-names>SM</given-names>
                    </name>
                    <name>
                      <surname>Penn</surname>
                      <given-names>DL</given-names>
                    </name>
                    <name>
                      <surname>Roberts</surname>
                      <given-names>DL</given-names>
                    </name>
                  </person-group>
                  <article-title>The functional significance of social cognition in schizophrenia: a review</article-title>
                  <source>Schizophr. Bull.</source>
                  <year>2006</year>
                  <volume>32</volume>
                  <issue>Suppl. 1</issue>
                  <fpage>S44</fpage>
                  <lpage>63</lpage>
                  <?supplied-pmid 16916889?>
                  <pub-id pub-id-type="pmid">16916889</pub-id>
                </element-citation>
              </ref>
              <ref id="CR2">
                <label>2.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fusar-Poli</surname>
                      <given-names>P</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Social dysfunction predicts two years clinical outcome in people at ultra high risk for psychosis</article-title>
                  <source>J. Psychiatr. Res.</source>
                  <year>2010</year>
                  <volume>44</volume>
                  <fpage>294</fpage>
                  <lpage>301</lpage>
                  <?supplied-pmid 19836755?>
                  <pub-id pub-id-type="pmid">19836755</pub-id>
                </element-citation>
              </ref>
              <ref id="CR3">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fusar-Poli</surname>
                      <given-names>P</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Cognitive functioning in prodromal psychosis: a meta-analysiscognitive functioning in prodromal psychosis</article-title>
                  <source>Arch. Gen. Psychiatry</source>
                  <year>2012</year>
                  <volume>69</volume>
                  <fpage>562</fpage>
                  <lpage>571</lpage>
                  <?supplied-pmid 22664547?>
                  <pub-id pub-id-type="pmid">22664547</pub-id>
                </element-citation>
              </ref>
              <ref id="CR4">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lincoln</surname>
                      <given-names>SH</given-names>
                    </name>
                    <name>
                      <surname>Norkett</surname>
                      <given-names>EM</given-names>
                    </name>
                    <name>
                      <surname>Frost</surname>
                      <given-names>KH</given-names>
                    </name>
                    <name>
                      <surname>Gonzalez-Heydrich</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>D’Angelo</surname>
                      <given-names>EJ</given-names>
                    </name>
                  </person-group>
                  <article-title>A developmental perspective on social-cognition difficulties in youth at clinical high risk for psychosis</article-title>
                  <source>Harv. Rev. Psychiatry</source>
                  <year>2017</year>
                  <volume>25</volume>
                  <fpage>4</fpage>
                  <lpage>14</lpage>
                  <?supplied-pmid 28059932?>
                  <pub-id pub-id-type="pmid">28059932</pub-id>
                </element-citation>
              </ref>
              <ref id="CR5">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Davies</surname>
                      <given-names>C</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Efficacy and acceptability of interventions for attenuated positive psychotic symptoms in individuals at clinical high risk of psychosis: a network meta-analysis</article-title>
                  <source>Front Psychiatry</source>
                  <year>2018</year>
                  <volume>9</volume>
                  <fpage>187</fpage>
                  <?supplied-pmid 29946270?>
                  <pub-id pub-id-type="pmid">29946270</pub-id>
                </element-citation>
              </ref>
              <ref id="CR6">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Davies</surname>
                      <given-names>C</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Lack of evidence to favor specific preventive interventions in psychosis: a network meta-analysis</article-title>
                  <source>World Psychiatry</source>
                  <year>2018</year>
                  <volume>17</volume>
                  <fpage>196</fpage>
                  <lpage>209</lpage>
                  <?supplied-pmid 29856551?>
                  <pub-id pub-id-type="pmid">29856551</pub-id>
                </element-citation>
              </ref>
              <ref id="CR7">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Amodio</surname>
                      <given-names>DM</given-names>
                    </name>
                    <name>
                      <surname>Frith</surname>
                      <given-names>CD</given-names>
                    </name>
                  </person-group>
                  <article-title>Meeting of minds: the medial frontal cortex and social cognition</article-title>
                  <source>Nat. Rev. Neurosci.</source>
                  <year>2006</year>
                  <volume>7</volume>
                  <fpage>268</fpage>
                  <lpage>277</lpage>
                  <?supplied-pmid 16552413?>
                  <pub-id pub-id-type="pmid">16552413</pub-id>
                </element-citation>
              </ref>
              <ref id="CR8">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Langdon</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Connors</surname>
                      <given-names>MH</given-names>
                    </name>
                    <name>
                      <surname>Still</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Ward</surname>
                      <given-names>PB</given-names>
                    </name>
                    <name>
                      <surname>Catts</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>Theory of mind and neurocognition in early psychosis: a quasi-experimental study</article-title>
                  <source>BMC Psychiatry</source>
                  <year>2014</year>
                  <volume>14</volume>
                  <fpage>316</fpage>
                  <?supplied-pmid 25472859?>
                  <pub-id pub-id-type="pmid">25472859</pub-id>
                </element-citation>
              </ref>
              <ref id="CR9">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ohmuro</surname>
                      <given-names>N</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Deficits of cognitive theory of mind and its relationship with functioning in individuals with an at-risk mental state and first-episode psychosis</article-title>
                  <source>Psychiatry Res.</source>
                  <year>2016</year>
                  <volume>243</volume>
                  <fpage>318</fpage>
                  <lpage>325</lpage>
                  <?supplied-pmid 27434201?>
                  <pub-id pub-id-type="pmid">27434201</pub-id>
                </element-citation>
              </ref>
              <ref id="CR10">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hur</surname>
                      <given-names>JW</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>General intellectual functioning as a buffer against theory-of-mind deficits in individuals at ultra-high risk for psychosis</article-title>
                  <source>Schizophr. Res.</source>
                  <year>2013</year>
                  <volume>149</volume>
                  <fpage>83</fpage>
                  <lpage>87</lpage>
                  <?supplied-pmid 23810120?>
                  <pub-id pub-id-type="pmid">23810120</pub-id>
                </element-citation>
              </ref>
              <ref id="CR11">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Healey</surname>
                      <given-names>ML</given-names>
                    </name>
                    <name>
                      <surname>Grossman</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Cognitive and affective perspective-taking: evidence for shared and dissociable anatomical substrates</article-title>
                  <source>Front. Neurol.</source>
                  <year>2018</year>
                  <volume>9</volume>
                  <fpage>491</fpage>
                  <?supplied-pmid 29988515?>
                  <pub-id pub-id-type="pmid">29988515</pub-id>
                </element-citation>
              </ref>
              <ref id="CR12">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Shamay-Tsoory</surname>
                      <given-names>SG</given-names>
                    </name>
                    <name>
                      <surname>Aharon-Peretz</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Perry</surname>
                      <given-names>D</given-names>
                    </name>
                  </person-group>
                  <article-title>Two systems for empathy: a double dissociation between emotional and cognitive empathy in inferior frontal gyrus versus ventromedial prefrontal lesions</article-title>
                  <source>Brain</source>
                  <year>2009</year>
                  <volume>132</volume>
                  <issue>Pt 3</issue>
                  <fpage>617</fpage>
                  <lpage>627</lpage>
                  <?supplied-pmid 18971202?>
                  <pub-id pub-id-type="pmid">18971202</pub-id>
                </element-citation>
              </ref>
              <ref id="CR13">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fan</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Duncan</surname>
                      <given-names>NW</given-names>
                    </name>
                    <name>
                      <surname>de Greck</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Northoff</surname>
                      <given-names>G</given-names>
                    </name>
                  </person-group>
                  <article-title>Is there a core neural network in empathy? An fMRI based quantitative meta-analysis</article-title>
                  <source>Neurosci. Biobehav. Rev.</source>
                  <year>2011</year>
                  <volume>35</volume>
                  <fpage>903</fpage>
                  <lpage>911</lpage>
                  <?supplied-pmid 20974173?>
                  <pub-id pub-id-type="pmid">20974173</pub-id>
                </element-citation>
              </ref>
              <ref id="CR14">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Brüne</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>An fMRI study of “theory of mind” in at-risk states of psychosis: comparison with manifest schizophrenia and healthy controls</article-title>
                  <source>Neuroimage</source>
                  <year>2011</year>
                  <volume>55</volume>
                  <fpage>329</fpage>
                  <lpage>337</lpage>
                  <?supplied-pmid 21147235?>
                  <pub-id pub-id-type="pmid">21147235</pub-id>
                </element-citation>
              </ref>
              <ref id="CR15">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Derntl</surname>
                      <given-names>B</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Empathy in individuals clinically at risk for psychosis: brain and behaviour</article-title>
                  <source>Br. J. Psychiatry</source>
                  <year>2015</year>
                  <volume>207</volume>
                  <fpage>407</fpage>
                  <lpage>413</lpage>
                  <?supplied-pmid 26294367?>
                  <pub-id pub-id-type="pmid">26294367</pub-id>
                </element-citation>
              </ref>
              <ref id="CR16">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Takano</surname>
                      <given-names>Y</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Neural basis for inferring false beliefs and social emotions in others among individuals with schizophrenia and those at ultra-high risk for psychosis</article-title>
                  <source>Psychiatry Res. Neuroimaging</source>
                  <year>2017</year>
                  <volume>259</volume>
                  <fpage>34</fpage>
                  <lpage>41</lpage>
                  <?supplied-pmid 27960147?>
                  <pub-id pub-id-type="pmid">27960147</pub-id>
                </element-citation>
              </ref>
              <ref id="CR17">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Meyer-Lindenberg</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Domes</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Kirsch</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Heinrichs</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine</article-title>
                  <source>Nat. Rev. Neurosci.</source>
                  <year>2011</year>
                  <volume>12</volume>
                  <fpage>524</fpage>
                  <lpage>538</lpage>
                  <?supplied-pmid 21852800?>
                  <pub-id pub-id-type="pmid">21852800</pub-id>
                </element-citation>
              </ref>
              <ref id="CR18">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Baskerville</surname>
                      <given-names>TA</given-names>
                    </name>
                    <name>
                      <surname>Douglas</surname>
                      <given-names>AJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Dopamine and oxytocin interactions underlying behaviors: potential contributions to behavioral disorders</article-title>
                  <source>CNS Neurosci. Ther.</source>
                  <year>2010</year>
                  <volume>16</volume>
                  <fpage>e92</fpage>
                  <lpage>e123</lpage>
                  <?supplied-pmid 20557568?>
                  <pub-id pub-id-type="pmid">20557568</pub-id>
                </element-citation>
              </ref>
              <ref id="CR19">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Feifel</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Shilling</surname>
                      <given-names>PD</given-names>
                    </name>
                    <name>
                      <surname>MacDonald</surname>
                      <given-names>K</given-names>
                    </name>
                  </person-group>
                  <article-title>A review of oxytocin’s effects on the positive, negative, and cognitive domains of schizophrenia</article-title>
                  <source>Biol. Psychiatry</source>
                  <year>2016</year>
                  <volume>79</volume>
                  <fpage>222</fpage>
                  <lpage>233</lpage>
                  <?supplied-pmid 26410353?>
                  <pub-id pub-id-type="pmid">26410353</pub-id>
                </element-citation>
              </ref>
              <ref id="CR20">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jobst</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Oxytocin and vasopressin levels are decreased in the plasma of male schizophrenia patients</article-title>
                  <source>Acta Neuropsychiatr.</source>
                  <year>2014</year>
                  <volume>26</volume>
                  <fpage>347</fpage>
                  <lpage>355</lpage>
                  <?supplied-pmid 25288094?>
                  <pub-id pub-id-type="pmid">25288094</pub-id>
                </element-citation>
              </ref>
              <ref id="CR21">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Strauss</surname>
                      <given-names>GP</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Plasma oxytocin levels predict social cue recognition in individuals with schizophrenia</article-title>
                  <source>Schizophr. Res.</source>
                  <year>2015</year>
                  <volume>162</volume>
                  <fpage>47</fpage>
                  <lpage>51</lpage>
                  <?supplied-pmid 25673435?>
                  <pub-id pub-id-type="pmid">25673435</pub-id>
                </element-citation>
              </ref>
              <ref id="CR22">
                <label>22.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bang</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Reduced DNA methylation of the oxytocin receptor gene is associated with anhedonia-asociality in women with recent-onset schizophrenia and ultra-high risk for psychosis</article-title>
                  <source>Schizophr. Bull.</source>
                  <year>2019</year>
                  <volume>45</volume>
                  <fpage>1279</fpage>
                  <lpage>1290</lpage>
                  <?supplied-pmid 31220321?>
                  <pub-id pub-id-type="pmid">31220321</pub-id>
                </element-citation>
              </ref>
              <ref id="CR23">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Domes</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Heinrichs</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Michel</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Berger</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Herpertz</surname>
                      <given-names>SC</given-names>
                    </name>
                  </person-group>
                  <article-title>Oxytocin improves “mind-reading” in humans</article-title>
                  <source>Biol. Psychiatry</source>
                  <year>2007</year>
                  <volume>61</volume>
                  <fpage>731</fpage>
                  <lpage>733</lpage>
                  <?supplied-pmid 17137561?>
                  <pub-id pub-id-type="pmid">17137561</pub-id>
                </element-citation>
              </ref>
              <ref id="CR24">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kosfeld</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Heinrichs</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Zak</surname>
                      <given-names>PJ</given-names>
                    </name>
                    <name>
                      <surname>Fischbacher</surname>
                      <given-names>U</given-names>
                    </name>
                    <name>
                      <surname>Fehr</surname>
                      <given-names>E</given-names>
                    </name>
                  </person-group>
                  <article-title>Oxytocin increases trust in humans</article-title>
                  <source>Nature</source>
                  <year>2005</year>
                  <volume>435</volume>
                  <fpage>673</fpage>
                  <lpage>676</lpage>
                  <?supplied-pmid 15931222?>
                  <pub-id pub-id-type="pmid">15931222</pub-id>
                </element-citation>
              </ref>
              <ref id="CR25">
                <label>25.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hurlemann</surname>
                      <given-names>R</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Oxytocin enhances amygdala-dependent, socially reinforced learning and emotional empathy in humans</article-title>
                  <source>J. Neurosci.</source>
                  <year>2010</year>
                  <volume>30</volume>
                  <fpage>4999</fpage>
                  <lpage>5007</lpage>
                  <?supplied-pmid 20371820?>
                  <pub-id pub-id-type="pmid">20371820</pub-id>
                </element-citation>
              </ref>
              <ref id="CR26">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Radke</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>de Bruijn</surname>
                      <given-names>ER</given-names>
                    </name>
                  </person-group>
                  <article-title>Does oxytocin affect mind-reading? A replication study</article-title>
                  <source>Psychoneuroendocrinology</source>
                  <year>2015</year>
                  <volume>60</volume>
                  <fpage>75</fpage>
                  <lpage>81</lpage>
                  <?supplied-pmid 26142239?>
                  <pub-id pub-id-type="pmid">26142239</pub-id>
                </element-citation>
              </ref>
              <ref id="CR27">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Averbeck</surname>
                      <given-names>BB</given-names>
                    </name>
                    <name>
                      <surname>Bobin</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Evans</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Shergill</surname>
                      <given-names>SS</given-names>
                    </name>
                  </person-group>
                  <article-title>Emotion recognition and oxytocin in patients with schizophrenia</article-title>
                  <source>Psychol. Med.</source>
                  <year>2012</year>
                  <volume>42</volume>
                  <fpage>259</fpage>
                  <lpage>266</lpage>
                  <?supplied-pmid 21835090?>
                  <pub-id pub-id-type="pmid">21835090</pub-id>
                </element-citation>
              </ref>
              <ref id="CR28">
                <label>28.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fischer-Shofty</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Improving social perception in schizophrenia: the role of oxytocin</article-title>
                  <source>Schizophr. Res.</source>
                  <year>2013</year>
                  <volume>146</volume>
                  <fpage>357</fpage>
                  <lpage>362</lpage>
                  <?supplied-pmid 23433504?>
                  <pub-id pub-id-type="pmid">23433504</pub-id>
                </element-citation>
              </ref>
              <ref id="CR29">
                <label>29.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Woolley</surname>
                      <given-names>JD</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Oxytocin administration enhances controlled social cognition in patients with schizophrenia</article-title>
                  <source>Psychoneuroendocrinology</source>
                  <year>2014</year>
                  <volume>47</volume>
                  <fpage>116</fpage>
                  <lpage>125</lpage>
                  <?supplied-pmid 25001961?>
                  <pub-id pub-id-type="pmid">25001961</pub-id>
                </element-citation>
              </ref>
              <ref id="CR30">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Guastella</surname>
                      <given-names>AJ</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A single dose of oxytocin nasal spray improves higher-order social cognition in schizophrenia</article-title>
                  <source>Schizophr. Res.</source>
                  <year>2015</year>
                  <volume>168</volume>
                  <fpage>628</fpage>
                  <lpage>633</lpage>
                  <?supplied-pmid 26150070?>
                  <pub-id pub-id-type="pmid">26150070</pub-id>
                </element-citation>
              </ref>
              <ref id="CR31">
                <label>31.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Michalopoulou</surname>
                      <given-names>PG</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The effects of a single dose of oxytocin on working memory in schizophrenia</article-title>
                  <source>Schizophr. Res.</source>
                  <year>2015</year>
                  <volume>162</volume>
                  <fpage>62</fpage>
                  <lpage>63</lpage>
                  <?supplied-pmid 25579054?>
                  <pub-id pub-id-type="pmid">25579054</pub-id>
                </element-citation>
              </ref>
              <ref id="CR32">
                <label>32.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cacciotti-Saija</surname>
                      <given-names>C</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A double-blind randomized controlled trial of oxytocin nasal spray and social cognition training for young people with early psychosis</article-title>
                  <source>Schizophr. Bull.</source>
                  <year>2015</year>
                  <volume>41</volume>
                  <fpage>483</fpage>
                  <lpage>493</lpage>
                  <?supplied-pmid 24962607?>
                  <pub-id pub-id-type="pmid">24962607</pub-id>
                </element-citation>
              </ref>
              <ref id="CR33">
                <label>33.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Shamay-Tsoory</surname>
                      <given-names>SG</given-names>
                    </name>
                  </person-group>
                  <article-title>The neural bases for empathy</article-title>
                  <source>Neuroscientist</source>
                  <year>2011</year>
                  <volume>17</volume>
                  <fpage>18</fpage>
                  <lpage>24</lpage>
                  <?supplied-pmid 21071616?>
                  <pub-id pub-id-type="pmid">21071616</pub-id>
                </element-citation>
              </ref>
              <ref id="CR34">
                <label>34.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Luminet</surname>
                      <given-names>O</given-names>
                    </name>
                    <name>
                      <surname>Grynberg</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Ruzette</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Mikolajczak</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Personality-dependent effects of oxytocin: greater social benefits for high alexithymia scorers</article-title>
                  <source>Biol. Psychol.</source>
                  <year>2011</year>
                  <volume>87</volume>
                  <fpage>401</fpage>
                  <lpage>406</lpage>
                  <?supplied-pmid 21641964?>
                  <pub-id pub-id-type="pmid">21641964</pub-id>
                </element-citation>
              </ref>
              <ref id="CR35">
                <label>35.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Davies</surname>
                      <given-names>C</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Oxytocin modulates hippocampal perfusion in people at clinical high risk for psychosis</article-title>
                  <source>Neuropsychopharmacology</source>
                  <year>2019</year>
                  <volume>44</volume>
                  <fpage>1300</fpage>
                  <lpage>1309</lpage>
                  <?supplied-pmid 30626906?>
                  <pub-id pub-id-type="pmid">30626906</pub-id>
                </element-citation>
              </ref>
              <ref id="CR36">
                <label>36.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Davies</surname>
                      <given-names>C</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Neurochemical effects of oxytocin in people at clinical high risk for psychosis</article-title>
                  <source>Eur. Neuropsychopharmacol.</source>
                  <year>2019</year>
                  <volume>29</volume>
                  <fpage>601</fpage>
                  <lpage>615</lpage>
                  <?supplied-pmid 30928180?>
                  <pub-id pub-id-type="pmid">30928180</pub-id>
                </element-citation>
              </ref>
              <ref id="CR37">
                <label>37.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Stone</surname>
                      <given-names>JM</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume</article-title>
                  <source>Biol. Psychiatry</source>
                  <year>2009</year>
                  <volume>66</volume>
                  <fpage>533</fpage>
                  <lpage>539</lpage>
                  <?supplied-pmid 19559402?>
                  <pub-id pub-id-type="pmid">19559402</pub-id>
                </element-citation>
              </ref>
              <ref id="CR38">
                <label>38.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fusar-Poli</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Byrne</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Badger</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Valmaggia</surname>
                      <given-names>LR</given-names>
                    </name>
                    <name>
                      <surname>McGuire</surname>
                      <given-names>PK</given-names>
                    </name>
                  </person-group>
                  <article-title>Outreach and support in south London (OASIS), 2001-2011: ten years of early diagnosis and treatment for young individuals at high clinical risk for psychosis</article-title>
                  <source>Eur. Psychiatry</source>
                  <year>2013</year>
                  <volume>28</volume>
                  <fpage>315</fpage>
                  <lpage>326</lpage>
                  <?supplied-pmid 23137782?>
                  <pub-id pub-id-type="pmid">23137782</pub-id>
                </element-citation>
              </ref>
              <ref id="CR39">
                <label>39.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fusar-Poli</surname>
                      <given-names>P</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Pan-London network for psychosis-prevention (PNP)</article-title>
                  <source>Front. Psychiatry</source>
                  <year>2019</year>
                  <volume>10</volume>
                  <fpage>707</fpage>
                  <?supplied-pmid 31681029?>
                  <pub-id pub-id-type="pmid">31681029</pub-id>
                </element-citation>
              </ref>
              <ref id="CR40">
                <label>40.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yung</surname>
                      <given-names>AR</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states</article-title>
                  <source>Aust. N. Z. J. Psychiatry</source>
                  <year>2005</year>
                  <volume>39</volume>
                  <fpage>964</fpage>
                  <lpage>971</lpage>
                  <?supplied-pmid 16343296?>
                  <pub-id pub-id-type="pmid">16343296</pub-id>
                </element-citation>
              </ref>
              <ref id="CR41">
                <label>41.</label>
                <mixed-citation publication-type="other">Fusar-Poli, P. et al. Unmet needs for treatment in 102 individuals with brief and limited intermittent psychotic symptoms (BLIPS): implications for current clinical recommendations. <italic>Epidemiol. Psychiatr. Sci.</italic><bold>29</bold>, e67, 1–9 (2019).</mixed-citation>
              </ref>
              <ref id="CR42">
                <label>42.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fusar-Poli</surname>
                      <given-names>P</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Diagnostic and prognostic significance of brief limited intermittent psychotic symptoms (BLIPS) in individuals at ultra high risk</article-title>
                  <source>Schizophr. Bull.</source>
                  <year>2017</year>
                  <volume>43</volume>
                  <fpage>48</fpage>
                  <lpage>56</lpage>
                  <?supplied-pmid 28053130?>
                  <pub-id pub-id-type="pmid">28053130</pub-id>
                </element-citation>
              </ref>
              <ref id="CR43">
                <label>43.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fusar-Poli</surname>
                      <given-names>P</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Prognosis of brief psychotic episodes: a meta-analysis</article-title>
                  <source>JAMA Psychiatry</source>
                  <year>2016</year>
                  <volume>73</volume>
                  <fpage>211</fpage>
                  <lpage>220</lpage>
                  <?supplied-pmid 26764163?>
                  <pub-id pub-id-type="pmid">26764163</pub-id>
                </element-citation>
              </ref>
              <ref id="CR44">
                <label>44.</label>
                <mixed-citation publication-type="other">Fusar-Poli, P. et al. towards a standard psychometric diagnostic interview for subjects at ultra high risk of psychosis: CAARMS versus SIPS. <italic>Psychiatry J.</italic><bold>2016</bold>, 7146341 (2016).</mixed-citation>
              </ref>
              <ref id="CR45">
                <label>45.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fusar-Poli</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Nelson</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Valmaggia</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Yung</surname>
                      <given-names>AR</given-names>
                    </name>
                    <name>
                      <surname>McGuire</surname>
                      <given-names>PK</given-names>
                    </name>
                  </person-group>
                  <article-title>Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: impact on psychopathology and transition to psychosis</article-title>
                  <source>Schizophr. Bull.</source>
                  <year>2014</year>
                  <volume>40</volume>
                  <fpage>120</fpage>
                  <lpage>131</lpage>
                  <?supplied-pmid 23180756?>
                  <pub-id pub-id-type="pmid">23180756</pub-id>
                </element-citation>
              </ref>
              <ref id="CR46">
                <label>46.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cornblatt</surname>
                      <given-names>BA</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Preliminary findings for two new measures of social and role functioning in the prodromal phase of schizophrenia</article-title>
                  <source>Schizophr. Bull.</source>
                  <year>2007</year>
                  <volume>33</volume>
                  <fpage>688</fpage>
                  <lpage>702</lpage>
                  <?supplied-pmid 17440198?>
                  <pub-id pub-id-type="pmid">17440198</pub-id>
                </element-citation>
              </ref>
              <ref id="CR47">
                <label>47.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bartz</surname>
                      <given-names>JA</given-names>
                    </name>
                    <name>
                      <surname>Zaki</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Bolger</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Ochsner</surname>
                      <given-names>KN</given-names>
                    </name>
                  </person-group>
                  <article-title>Social effects of oxytocin in humans: context and person matter</article-title>
                  <source>Trends Cogn. Sci.</source>
                  <year>2011</year>
                  <volume>15</volume>
                  <fpage>301</fpage>
                  <lpage>309</lpage>
                  <?supplied-pmid 21696997?>
                  <pub-id pub-id-type="pmid">21696997</pub-id>
                </element-citation>
              </ref>
              <ref id="CR48">
                <label>48.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Baron-Cohen</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Wheelwright</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Hill</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Raste</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Plumb</surname>
                      <given-names>I</given-names>
                    </name>
                  </person-group>
                  <article-title>The “Reading the Mind in the Eyes” Test revised version: a study with normal adults, and adults with Asperger syndrome or high-functioning autism</article-title>
                  <source>J. Child Psychol. Psychiatry</source>
                  <year>2001</year>
                  <volume>42</volume>
                  <fpage>241</fpage>
                  <lpage>251</lpage>
                  <?supplied-pmid 11280420?>
                  <pub-id pub-id-type="pmid">11280420</pub-id>
                </element-citation>
              </ref>
              <ref id="CR49">
                <label>49.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Paloyelis</surname>
                      <given-names>Y</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A spatiotemporal profile of in vivo cerebral blood flow changes following intranasal oxytocin in humans</article-title>
                  <source>Biol. Psychiatry</source>
                  <year>2016</year>
                  <volume>79</volume>
                  <fpage>693</fpage>
                  <lpage>705</lpage>
                  <?supplied-pmid 25499958?>
                  <pub-id pub-id-type="pmid">25499958</pub-id>
                </element-citation>
              </ref>
              <ref id="CR50">
                <label>50.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Aoki</surname>
                      <given-names>Y</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Oxytocin improves behavioural and neural deficits in inferring others’ social emotions in autism</article-title>
                  <source>Brain</source>
                  <year>2014</year>
                  <volume>137</volume>
                  <issue>Pt 11</issue>
                  <fpage>3073</fpage>
                  <lpage>3086</lpage>
                  <?supplied-pmid 25149412?>
                  <pub-id pub-id-type="pmid">25149412</pub-id>
                </element-citation>
              </ref>
              <ref id="CR51">
                <label>51.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Petersson</surname>
                      <given-names>KM</given-names>
                    </name>
                    <name>
                      <surname>Nichols</surname>
                      <given-names>TE</given-names>
                    </name>
                    <name>
                      <surname>Poline</surname>
                      <given-names>JB</given-names>
                    </name>
                    <name>
                      <surname>Holmes</surname>
                      <given-names>AP</given-names>
                    </name>
                  </person-group>
                  <article-title>Statistical limitations in functional neuroimaging. II. Signal detection and statistical inference</article-title>
                  <source>Philos. Trans. R. Soc. Lond. B: Biol. Sci.</source>
                  <year>1999</year>
                  <volume>354</volume>
                  <fpage>1261</fpage>
                  <lpage>1281</lpage>
                  <pub-id pub-id-type="pmid">10466150</pub-id>
                </element-citation>
              </ref>
              <ref id="CR52">
                <label>52.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Woo</surname>
                      <given-names>CW</given-names>
                    </name>
                    <name>
                      <surname>Krishnan</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Wager</surname>
                      <given-names>TD</given-names>
                    </name>
                  </person-group>
                  <article-title>Cluster-extent based thresholding in fMRI analyses: pitfalls and recommendations</article-title>
                  <source>Neuroimage</source>
                  <year>2014</year>
                  <volume>91</volume>
                  <fpage>412</fpage>
                  <lpage>419</lpage>
                  <?supplied-pmid 24412399?>
                  <pub-id pub-id-type="pmid">24412399</pub-id>
                </element-citation>
              </ref>
              <ref id="CR53">
                <label>53.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Geng</surname>
                      <given-names>Y</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Oxytocin enhancement of emotional empathy: generalization across cultures and effects on amygdala activity</article-title>
                  <source>Front. Neurosci.</source>
                  <year>2018</year>
                  <volume>12</volume>
                  <fpage>512</fpage>
                  <?supplied-pmid 30108475?>
                  <pub-id pub-id-type="pmid">30108475</pub-id>
                </element-citation>
              </ref>
              <ref id="CR54">
                <label>54.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wildgruber</surname>
                      <given-names>D</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Identification of emotional intonation evaluated by fMRI</article-title>
                  <source>Neuroimage</source>
                  <year>2005</year>
                  <volume>24</volume>
                  <fpage>1233</fpage>
                  <lpage>1241</lpage>
                  <?supplied-pmid 15670701?>
                  <pub-id pub-id-type="pmid">15670701</pub-id>
                </element-citation>
              </ref>
              <ref id="CR55">
                <label>55.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kesler-West</surname>
                      <given-names>ML</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Neural substrates of facial emotion processing using fMRI</article-title>
                  <source>Brain Res. Cogn. Brain Res.</source>
                  <year>2001</year>
                  <volume>11</volume>
                  <fpage>213</fpage>
                  <lpage>226</lpage>
                  <?supplied-pmid 11275483?>
                  <pub-id pub-id-type="pmid">11275483</pub-id>
                </element-citation>
              </ref>
              <ref id="CR56">
                <label>56.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Iacoboni</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Dapretto</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>The mirror neuron system and the consequences of its dysfunction</article-title>
                  <source>Nat. Rev. Neurosci.</source>
                  <year>2006</year>
                  <volume>7</volume>
                  <fpage>942</fpage>
                  <lpage>951</lpage>
                  <?supplied-pmid 17115076?>
                  <pub-id pub-id-type="pmid">17115076</pub-id>
                </element-citation>
              </ref>
              <ref id="CR57">
                <label>57.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Iacoboni</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Imitation, empathy, and mirror neurons</article-title>
                  <source>Annu. Rev. Psychol.</source>
                  <year>2009</year>
                  <volume>60</volume>
                  <fpage>653</fpage>
                  <lpage>670</lpage>
                  <?supplied-pmid 18793090?>
                  <pub-id pub-id-type="pmid">18793090</pub-id>
                </element-citation>
              </ref>
              <ref id="CR58">
                <label>58.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wigton</surname>
                      <given-names>R</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Neurophysiological effects of acute oxytocin administration: systematic review and meta-analysis of placebo-controlled imaging studies</article-title>
                  <source>J. Psychiatry Neurosci.</source>
                  <year>2015</year>
                  <volume>40</volume>
                  <fpage>E1</fpage>
                  <lpage>E22</lpage>
                  <?supplied-pmid 25520163?>
                  <pub-id pub-id-type="pmid">25520163</pub-id>
                </element-citation>
              </ref>
              <ref id="CR59">
                <label>59.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tops</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The role of oxytocin in familiarization-habituation responses to social novelty</article-title>
                  <source>Front. Psychol.</source>
                  <year>2013</year>
                  <volume>4</volume>
                  <fpage>761</fpage>
                  <?supplied-pmid 24151482?>
                  <pub-id pub-id-type="pmid">24151482</pub-id>
                </element-citation>
              </ref>
              <ref id="CR60">
                <label>60.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tops</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Koole</surname>
                      <given-names>SL</given-names>
                    </name>
                    <name>
                      <surname>IJzerman</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Buisman-Pijlman</surname>
                      <given-names>FT</given-names>
                    </name>
                  </person-group>
                  <article-title>Why social attachment and oxytocin protect against addiction and stress: Insights from the dynamics between ventral and dorsal corticostriatal systems</article-title>
                  <source>Pharm. Biochem. Behav.</source>
                  <year>2014</year>
                  <volume>119</volume>
                  <fpage>39</fpage>
                  <lpage>48</lpage>
                </element-citation>
              </ref>
              <ref id="CR61">
                <label>61.</label>
                <mixed-citation publication-type="other">Modinos, G. et al. Association of adverse outcomes with emotion processing and its neural substrate in individuals at clinical high risk for psychosis. <italic>JAMA Psychiatry</italic><bold>77</bold>, 190–200 (2019).</mixed-citation>
              </ref>
              <ref id="CR62">
                <label>62.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Horton</surname>
                      <given-names>LE</given-names>
                    </name>
                    <name>
                      <surname>Bridgwater</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Haas</surname>
                      <given-names>GL</given-names>
                    </name>
                  </person-group>
                  <article-title>Emotion recognition and social skills in child and adolescent offspring of parents with schizophrenia</article-title>
                  <source>Cogn. Neuropsychiatry</source>
                  <year>2017</year>
                  <volume>22</volume>
                  <fpage>175</fpage>
                  <lpage>185</lpage>
                  <?supplied-pmid 28288532?>
                  <pub-id pub-id-type="pmid">28288532</pub-id>
                </element-citation>
              </ref>
              <ref id="CR63">
                <label>63.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tillman</surname>
                      <given-names>R</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Oxytocin enhances the neural efficiency of social perception</article-title>
                  <source>Front. Hum. Neurosci.</source>
                  <year>2019</year>
                  <volume>13</volume>
                  <fpage>71</fpage>
                  <?supplied-pmid 30914935?>
                  <pub-id pub-id-type="pmid">30914935</pub-id>
                </element-citation>
              </ref>
              <ref id="CR64">
                <label>64.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Riem</surname>
                      <given-names>MM</given-names>
                    </name>
                    <name>
                      <surname>Bakermans-Kranenburg</surname>
                      <given-names>MJ</given-names>
                    </name>
                    <name>
                      <surname>Voorthuis</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>van IJzendoorn</surname>
                      <given-names>MH</given-names>
                    </name>
                  </person-group>
                  <article-title>Oxytocin effects on mind-reading are moderated by experiences of maternal love withdrawal: an fMRI study</article-title>
                  <source>Prog. Neuropsychopharmacol. Biol. Psychiatry</source>
                  <year>2014</year>
                  <volume>51</volume>
                  <fpage>105</fpage>
                  <lpage>112</lpage>
                  <?supplied-pmid 24486563?>
                  <pub-id pub-id-type="pmid">24486563</pub-id>
                </element-citation>
              </ref>
              <ref id="CR65">
                <label>65.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Feeser</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Oxytocin improves mentalizing—pronounced effects for individuals with attenuated ability to empathize</article-title>
                  <source>Psychoneuroendocrinology</source>
                  <year>2015</year>
                  <volume>53</volume>
                  <fpage>223</fpage>
                  <lpage>232</lpage>
                  <?supplied-pmid 25638480?>
                  <pub-id pub-id-type="pmid">25638480</pub-id>
                </element-citation>
              </ref>
              <ref id="CR66">
                <label>66.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Oakley</surname>
                      <given-names>BFM</given-names>
                    </name>
                    <name>
                      <surname>Brewer</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Bird</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Catmur</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <article-title>Theory of mind is not theory of emotion: a cautionary note on the Reading the Mind in the Eyes Test</article-title>
                  <source>J. Abnorm. Psychol.</source>
                  <year>2016</year>
                  <volume>125</volume>
                  <fpage>818</fpage>
                  <lpage>823</lpage>
                  <?supplied-pmid 27505409?>
                  <pub-id pub-id-type="pmid">27505409</pub-id>
                </element-citation>
              </ref>
              <ref id="CR67">
                <label>67.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rutigliano</surname>
                      <given-names>G</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Persistence or recurrence of non-psychotic comorbid mental disorders associated with 6-year poor functional outcomes in patients at ultra high risk for psychosis</article-title>
                  <source>J. Affect Disord.</source>
                  <year>2016</year>
                  <volume>203</volume>
                  <fpage>101</fpage>
                  <lpage>110</lpage>
                  <?supplied-pmid 27285723?>
                  <pub-id pub-id-type="pmid">27285723</pub-id>
                </element-citation>
              </ref>
              <ref id="CR68">
                <label>68.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rilling</surname>
                      <given-names>JK</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Sex differences in the neural and behavioral response to intranasal oxytocin and vasopressin during human social interaction</article-title>
                  <source>Psychoneuroendocrinology</source>
                  <year>2014</year>
                  <volume>39</volume>
                  <fpage>237</fpage>
                  <lpage>248</lpage>
                  <?supplied-pmid 24157401?>
                  <pub-id pub-id-type="pmid">24157401</pub-id>
                </element-citation>
              </ref>
              <ref id="CR69">
                <label>69.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fusar-Poli</surname>
                      <given-names>P</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Heterogeneity of psychosis risk within individuals at clinical high risk: a meta-analytical stratification</article-title>
                  <source>JAMA Psychiatry</source>
                  <year>2016</year>
                  <volume>73</volume>
                  <fpage>113</fpage>
                  <lpage>120</lpage>
                  <?supplied-pmid 26719911?>
                  <pub-id pub-id-type="pmid">26719911</pub-id>
                </element-citation>
              </ref>
              <ref id="CR70">
                <label>70.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Comparelli</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Emotion recognition impairment is present early and is stable throughout the course of schizophrenia</article-title>
                  <source>Schizophr. Res.</source>
                  <year>2013</year>
                  <volume>143</volume>
                  <fpage>65</fpage>
                  <lpage>69</lpage>
                  <?supplied-pmid 23218561?>
                  <pub-id pub-id-type="pmid">23218561</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
